← FDA DRUG APPROVALS

FDA ANDA · ANDA075962

TRAMADOL HYDROCHLORIDE

Sponsor: WATSON LABS

APPLICATION
ANDA075962
TYPE
ANDA
ORIGINAL APPROVAL
2002-06-24
LATEST ACTION
2024-10-31
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

TRAMADOL HYDROCHLORIDEDiscontinued
TRAMADOL HYDROCHLORIDE 50MG · TABLET · ORAL

Approval history

2024-10-31REMS · Supplement 12AP
2023-12-18Labeling · Supplement 10 · standardAP
2018-09-18REMS · Supplement 9AP
2005-01-03Labeling · Supplement 5AP
2004-11-18Labeling · Supplement 6AP
2002-06-24OriginalReviewAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →